NOROVIRUS ACUTE GASTROENTERITIS
Clinical trials for NOROVIRUS ACUTE GASTROENTERITIS explained in plain language.
Never miss a new study
Get alerted when new NOROVIRUS ACUTE GASTROENTERITIS trials appear
Sign up with your email to follow new studies for NOROVIRUS ACUTE GASTROENTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New mRNA vaccine aims to stop the stomach flu
⭐️ VACCINE ⭐️ OngoingThis large Phase 3 study is testing an mRNA vaccine called mRNA-1403 to prevent norovirus, a common cause of severe stomach upset and diarrhea. About 38,000 adults aged 18 and older will receive either the vaccine or a placebo. The goal is to see if the vaccine can safely prevent…
Matched conditions: NOROVIRUS ACUTE GASTROENTERITIS
Phase: PHASE3 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:33 UTC
-
MRNA technology takes on the stomach flu: moderna launches norovirus vaccine trial
⭐️ VACCINE ⭐️ OngoingThis study tests two experimental mRNA vaccines, mRNA-1403 and mRNA-1405, designed to prevent norovirus, a common cause of severe vomiting and diarrhea. Around 1,400 healthy adults aged 18 to 80 will receive either a vaccine or a placebo. The main goals are to check safety and me…
Matched conditions: NOROVIRUS ACUTE GASTROENTERITIS
Phase: PHASE1, PHASE2 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:03 UTC